TriMas Corporation (NASDAQ:TRS - Free Report) - Analysts at KeyCorp issued their Q4 2025 earnings per share (EPS) estimates for TriMas in a research note issued to investors on Tuesday, August 12th. KeyCorp analyst K. Newman expects that the industrial products company will post earnings of $0.44 per share for the quarter. KeyCorp currently has a "Overweight" rating and a $45.00 target price on the stock. The consensus estimate for TriMas' current full-year earnings is $1.69 per share. KeyCorp also issued estimates for TriMas' Q1 2026 earnings at $0.58 EPS, Q4 2026 earnings at $0.55 EPS and FY2026 earnings at $2.53 EPS.
A number of other analysts have also recently issued reports on TRS. Wall Street Zen raised TriMas from a "hold" rating to a "buy" rating in a report on Sunday, June 1st. BWS Financial reaffirmed a "buy" rating and issued a $45.00 price target (up previously from $40.00) on shares of TriMas in a report on Wednesday, July 30th.
Read Our Latest Report on TRS
TriMas Stock Performance
Shares of TRS stock traded down $0.33 on Friday, hitting $36.65. 32,292 shares of the stock were exchanged, compared to its average volume of 418,515. The company has a current ratio of 2.59, a quick ratio of 1.44 and a debt-to-equity ratio of 0.59. The firm has a market capitalization of $1.49 billion, a PE ratio of 40.29 and a beta of 0.66. TriMas has a one year low of $19.33 and a one year high of $37.49. The firm's 50 day moving average is $30.67 and its two-hundred day moving average is $25.97.
TriMas (NASDAQ:TRS - Get Free Report) last announced its quarterly earnings data on Tuesday, July 29th. The industrial products company reported $0.61 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.50 by $0.11. The firm had revenue of $274.76 million during the quarter, compared to the consensus estimate of $251.18 million. TriMas had a return on equity of 11.49% and a net margin of 3.83%. The business's revenue for the quarter was up 14.2% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.43 EPS.
Hedge Funds Weigh In On TriMas
Several institutional investors and hedge funds have recently bought and sold shares of the stock. Bank of America Corp DE grew its position in TriMas by 0.3% during the 2nd quarter. Bank of America Corp DE now owns 3,660,001 shares of the industrial products company's stock worth $104,713,000 after acquiring an additional 9,602 shares during the last quarter. Pzena Investment Management LLC grew its position in TriMas by 2.0% during the 2nd quarter. Pzena Investment Management LLC now owns 2,177,761 shares of the industrial products company's stock worth $62,306,000 after acquiring an additional 42,207 shares during the last quarter. Medina Value Partners LLC grew its position in TriMas by 2.9% during the 4th quarter. Medina Value Partners LLC now owns 1,034,882 shares of the industrial products company's stock worth $25,448,000 after acquiring an additional 28,851 shares during the last quarter. Irenic Capital Management LP bought a new stake in shares of TriMas in the 1st quarter worth approximately $19,997,000. Finally, Advisory Research Inc. grew its position in shares of TriMas by 41.2% in the 4th quarter. Advisory Research Inc. now owns 754,089 shares of the industrial products company's stock worth $18,543,000 after buying an additional 220,000 shares during the last quarter. 99.42% of the stock is currently owned by institutional investors.
Insider Transactions at TriMas
In other news, Director Shawn Sedaghat acquired 410,172 shares of the firm's stock in a transaction that occurred on Wednesday, May 21st. The shares were bought at an average cost of $25.43 per share, with a total value of $10,430,673.96. Following the acquisition, the director owned 1,810,821 shares in the company, valued at approximately $46,049,178.03. This represents a 29.28% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Adrianne Shapira acquired 4,000 shares of the firm's stock in a transaction that occurred on Thursday, June 5th. The shares were purchased at an average cost of $25.82 per share, for a total transaction of $103,280.00. Following the completion of the acquisition, the director owned 8,476 shares in the company, valued at $218,850.32. This represents a 89.37% increase in their position. The disclosure for this purchase can be found here. Over the last three months, insiders have purchased 848,232 shares of company stock worth $21,644,995. 14.20% of the stock is currently owned by insiders.
TriMas Announces Dividend
The company also recently disclosed a quarterly dividend, which was paid on Tuesday, August 12th. Investors of record on Tuesday, August 5th were issued a dividend of $0.04 per share. This represents a $0.16 dividend on an annualized basis and a dividend yield of 0.4%. The ex-dividend date of this dividend was Tuesday, August 5th. TriMas's dividend payout ratio (DPR) is currently 17.58%.
About TriMas
(
Get Free Report)
TriMas Corporation engages in the design, development, manufacture, and sale of products for consumer products, aerospace, and industrial markets worldwide. The company operates through Packaging, Aerospace, and Specialty Products segments. The Packaging segment offers dispensing products, such as foaming and sanitizer pumps, lotion and hand soap pumps, beverage dispensers, perfume sprayers, and nasal and trigger sprayers; polymeric and steel caps and closures comprising food lids, flip-top and beverage closures, child resistance caps, drum and pail closures, and flexible spouts; polymeric jar products; integrated dispensers; bag-in-box products; and consumable vascular delivery and diagnostic test components under the Rieke, Taplast, Affaba & Ferrari, Intertech, Omega, and Rapak brands.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider TriMas, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and TriMas wasn't on the list.
While TriMas currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for August 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report